Vials
5, 10, 15, 20, 30, 40, 50 and 60 mg vials. Neutral label by default; your own label, carton and insert from 100 kits (1,000 vials).
SeqLine Bio · Catalog · Tirzepatide
GLP-1 family peptide · research use only
A synthetic peptide of the GLP-1 family (CAS 2023788-19-2), supplied lyophilized in vials from 5 to 60 mg. HPLC purity and MS identity on each lot COA.
An FDA proposal dated 2026-04-30 would take GLP-1 medications out of the bulk-substance framework. Until the proposal is final, check the current status before any US outsourcing-facility use. SeqLine Bio positions tirzepatide for Research use only. Read the GLP-1 2026 update →
Photo of the standard vial. Each lot carries its own lot number on the label and on its COA.
| Compound | Tirzepatide |
|---|---|
| CAS number | 2023788-19-2 |
| Class | Dual GIP / GLP-1 receptor agonist (research) |
| Molecular weight | ≈ 4813.5 g/mol |
| Form | Lyophilized powder, glass vial |
| HPLC purity | Specification NLT 98.0%; current lots 98.88–99.46% |
| Vial formats | 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg |
| Documentation | Lot COA with HPLC purity and MS identity |
| Distribution scope | B2B research-use supply to supported destinations; product and import requirements confirmed before payment. View shipping coverage → |
| Storage | 2–8 °C protected from light; long-term −20 °C |
| Order type | Minimum order | Dispatch window |
|---|---|---|
| Neutral-label sample from confirmed stock | 1 kit (10 vials) | Within 3 business days after written payment confirmation. |
| Neutral-label sample requiring preparation | 1 kit (10 vials) | 3–7 business days after specification and payment confirmation. |
| Made-to-order production | 100 kits (1,000 vials) | 7–15 business days after specification and payment confirmation. |
| Private-label OEM | 100 kits (1,000 vials) | 7–15 business days after specification, payment and artwork approval. |
Sample eligibility does not confirm current stock. Availability, lot and dispatch date are confirmed before payment. Kit price steps at 10, 100 and 1,000 kits do not change these minimums. Transit and customs are additional.
A tirzepatide quote needs your destination country and buyer type. US regulated facilities that ask are pointed to the FDA proposal and offered non-GLP-1 compounds instead.
Need to verify the supplier before ordering? Supplier Verification & Buyer Due Diligence →
What it is
Tirzepatide is a synthetic peptide in the GLP-1 family, listed in the spec table as a dual GIP / GLP-1 receptor agonist. CAS 2023788-19-2, molecular weight about 4813.5 g/mol. Supplied as lyophilized powder in glass vials; store at 2–8 °C protected from light, or at −20 °C for long-term storage.
What you get
5, 10, 15, 20, 30, 40, 50 and 60 mg vials. Neutral label by default; your own label, carton and insert from 100 kits (1,000 vials).
A COA for the lot you receive, with HPLC purity against our NLT 98.0% release specification and MS molecular-weight identity. Published lots are in the COA library; independent testing is welcome.
Sample orders start at 1 kit (10 vials) for eligible products. Confirmed stock: within 3 business days after written payment confirmation; samples requiring preparation: 3–7 business days after specification and payment confirmation. Stock and the dispatch date are confirmed before payment. Production lots dispatch in 7–15 business days after specification and payment confirmation. Private label also requires artwork approval. Transit and customs are additional.
FAQ
An FDA proposal dated 2026-04-30 would take GLP-1 medications out of the bulk-substance framework. Once final, US outsourcing facilities could no longer compound tirzepatide from bulk substance. SeqLine Bio supplies tirzepatide as a research peptide only; every quote needs a destination country and buyer track. See the GLP-1 2026 update.
Yes. Other fill weights and raw Tirzepatide powder are quoted on request. Include the target amount and specification in your RFQ.
Yes. The quotation includes the COA for the lot you would receive, and published lots are listed in the public COA library. A confirmed quality issue is replaced or refunded under our quality policy.
Related
Current Batch COA
One COA per published Tirzepatide lot, listed by strength. Each shows the HPLC purity and MS molecular weight for that lot. You are welcome to have a vial tested independently; a confirmed out-of-specification result is replaced or refunded under the quality policy.